AP
Ascendis Pharma AS
🇺🇸XNAS.ASNDUnited StatesHealthcare
$246.05USDup +6.28 (+2.62%)OpenDelayed4:15 PM
Price$246.05+6.28 (+2.62%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- DK0060615755
- CUSIP
- 04351P101
Company
- Employees
- 1,189
- Headquarters
- Hellerup, United States
- Website
- https://ascendispharma.com
- CEO
- Mr. Jan Moller Mikkelsen
Market
- Shares outstanding
- 65.8M
- Market cap
- $16.19B
Highlights
- Market cap
- $15.77B
- EPS LTM
- €11.49calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- €1.05B+114.85%up year on year
- Net income
- €755.85M+378.76%up year on year
- Gross margin
- 90.19%+6.25%up year on year
- Free cash flow
- €336.9M+297.19%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.